• Explore /
  • Poster
  • / Phase I trial of a novel DNA vaccine in patients (pts) with smoldering Waldenstrom macroglobulinemia (sWM).

Phase I trial of a novel DNA vaccine in patients (pts) with smoldering Waldenstrom macroglobulinemia (sWM).

Abstract Poster

Authors

null

Sheeba K. Thomas

The University of Texas MD Anderson Cancer Center, Houston, TX

Sheeba K. Thomas , Soungchul Cha , Sapna R Parshottam , Sheetal S Rao , Jasper B. Olsem , Brandon N. Crumpton , Lei Feng , Hans Chulhee Lee , Elisabet Esteve Manasanch , Donna M. Weber , Krina K. Patel , Robert Z. Orlowski , Sattva Swarup Neelapu , Larry W. Kwak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Plasma Cell Dyscrasia

Track

Hematologic Malignancies—Plasma Cell Dyscrasia

Sub Track

Plasma Cell Disorders

Clinical Trial Registration Number

NCT01209871

Citation

J Clin Oncol 37, 2019 (suppl; abstr 8050)

DOI

10.1200/JCO.2019.37.15_suppl.8050

Abstract #

8050

Poster Bd #

376

Abstract Disclosures

Similar Posters

First Author: Chrisann Kyi

First Author: Marka Crittenden

First Author: Neil Lorne Berinstein

First Author: Michael Bitzer